Fox Run Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,566
Closed -$105K 991
2025
Q3
$105K Sell
10,566
-9,631
-48% -$100K 0.02% 858
2025
Q2
$200K Buy
+20,197
New +$213K 0.03% 750
2025
Q1
Sell
-69,185
Closed -$883K 980
2024
Q4
$883K Buy
+69,185
New +$837K 0.16% 206
2018
Q4
Sell
-26,942
Closed -$334K 563
2018
Q3
$334K Buy
+26,942
New +$364K 0.15% 312
2018
Q1
Sell
-13,750
Closed -$257K 764
2017
Q4
$257K Buy
+13,750
New +$276K 0.08% 509
2017
Q3
Sell
-16,400
Closed -$158K 718
2017
Q2
$158K Buy
+16,400
New +$106K 0.05% 569
2016
Q3
Sell
-20,200
Closed -$295K 529
2016
Q2
$295K Buy
+20,200
New +$345K 0.14% 293
2016
Q1
Sell
-15,600
Closed -$377K 448
2015
Q4
$377K Buy
+15,600
New +$391K 0.29% 98

Other funds holding DVAX

Fox Run Management's DVAX Position: Q4 2025 in Review

Fox Run Management sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 10,566 shares — an estimated $105K sold.

Fox Run Management first reported a position in DVAX in Q4 2015 and held it in 8 quarters. The position peaked at $883K in Q4 2024. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Fox Run Management reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Fox Run Management sold 10,566 Dynavax Technologies shares in Q4 2025, an estimated $105K.
  • Fox Run Management first reported a position in Dynavax Technologies in Q4 2015 and held it in 8 quarters.
  • Fox Run Management's Dynavax Technologies position peaked at $883K in Q4 2024.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Fox Run Management's 13F filing for Q4 2025, filed 11 Feb 2026.